Detalles de la búsqueda
1.
Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process.
New Microbiol
; 46(4): 367-380, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252048
2.
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.
J Antimicrob Chemother
; 78(9): 2315-2322, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534393
3.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
J Med Virol
; 95(10): e29149, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805832
4.
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital.
Virol J
; 20(1): 214, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37723564
5.
Pillars of long-term antiretroviral therapy success.
Pharmacol Res
; 196: 106898, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37648103
6.
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients?
AIDS Behav
; 27(4): 1173-1181, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156175
7.
Reporting a single case of cystic echinococcosis in retroperitoneal mass of uncertain origin.
Parasitol Res
; 123(1): 40, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38095718
8.
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic.
Psychol Health Med
; 28(9): 2562-2578, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287347
9.
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.
J Med Virol
; 94(10): 4970-4974, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638227
10.
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV.
J Neurovirol
; 28(3): 422-429, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718852
11.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
HIV Med
; 22(9): 843-853, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318591
12.
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study.
AIDS Care
; 33(9): 1159-1166, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33172289
13.
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study.
J Antimicrob Chemother
; 75(6): 1599-1603, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32101614
14.
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
J Neurovirol
; 26(6): 899-907, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32839950
15.
Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy.
J Antimicrob Chemother
; 79(2): 473-475, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38156521
16.
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.
J Neurovirol
; 25(6): 866-873, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31281946
17.
Liver fibrosis is associated with cognitive impairment in people living with HIV.
Infection
; 47(4): 589-593, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30784024
18.
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
BMC Infect Dis
; 19(1): 59, 2019 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30654739
19.
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
J Antimicrob Chemother
; 78(7): 1808-1809, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220765
20.
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy.
J Antimicrob Chemother
; 73(7): 1949-1954, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788156